Murphy RJ

School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand. Electronic address: robin.murphy@auckland.ac.nz.

9 papers · ORCID

ArticlePsilocybin

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.

Kothiwala FM, Murphy RJ, Alshakhouri M +5

Europe PMC2026
ArticleLSD

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +11

Europe PMC2026
ArticleLSD

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers.

Morse JD, Jeong SH, Murphy RJ +2

Europe PMC2025
ArticleLSD

Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide.

Murphy RJ, Sumner RL, Godfrey K +4

Europe PMC2025
ArticleLSD

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Daldegan-Bueno D, Donegan CJ, Forsyth A +16

Europe PMC2024
ArticleLSD

Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.

Murphy RJ, Godfrey K, Shaw AD +2

Europe PMC2024
ArticleLSD

Microdosing Psychedelics: Current Evidence From Controlled Studies.

Murphy RJ, Muthukumaraswamy S, de Wit H

Europe PMC2024
ArticleLSD

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Murphy RJ, Sumner R, Evans W +10

Europe PMC2023
ArticleLSD

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Murphy RJ, Sumner RL, Evans W +8

Europe PMC2021